Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Methods for colon perfusion assessment].

Khirurgiia·2026
Same author

[D2 and D3 lymph node dissection for colon cancer].

Khirurgiia·2024
Same author

[Fluorescence lymphoscopy with sentinel lymph node biopsy in research of lymphatic flow in early gastric cancer].

Khirurgiia·2024
Same author

[The first experience of fluorescent angiography with indocyanine green in primary esophagoplasty with gastric conduit in patients with malignant tumors of the esophagus].

Khirurgiia·2023
Same author

[Modern possibilities of fluorescent imaging in liver surgery].

Khirurgiia·2023
Same author

[Interim results and safety assessment of indocyanine green peritumoral injection for regional lymphatic outflow area mapping in colon cancer as a part of the ISCAPE TRIAL].

Khirurgiia·2023

Related Experiment Video

Updated: Apr 6, 2026

Low-Cost Single-Port LoCoSP Device for a Transcervical Approach in Minimally Invasive Transhiatal Esophagectomy
09:04

Low-Cost Single-Port LoCoSP Device for a Transcervical Approach in Minimally Invasive Transhiatal Esophagectomy

Published on: September 11, 2021

3.4K

[MINIMALLY INVASIVE ESOPHAGECTOMY].

E V Levchenko, N V Khandogin, A M Karachun

    Voprosy Onkologii
    |August 6, 2015
    PubMed
    Summary

    Minimally invasive esophagectomy is a viable treatment for esophageal cancer, demonstrating good oncological outcomes and acceptable short-term results in a study of 54 patients. This approach offers a tolerable option for patients undergoing complex cancer treatment.

    More Related Videos

    An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
    09:40

    An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

    Published on: April 17, 2020

    15.5K
    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    489

    Related Experiment Videos

    Last Updated: Apr 6, 2026

    Low-Cost Single-Port LoCoSP Device for a Transcervical Approach in Minimally Invasive Transhiatal Esophagectomy
    09:04

    Low-Cost Single-Port LoCoSP Device for a Transcervical Approach in Minimally Invasive Transhiatal Esophagectomy

    Published on: September 11, 2021

    3.4K
    An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
    09:40

    An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function

    Published on: April 17, 2020

    15.5K
    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    489

    Area of Science:

    • Oncology
    • Surgical Oncology
    • Gastroenterology

    Context:

    • Esophageal cancer treatment often involves complex surgical procedures.
    • Minimally invasive esophagectomy is an evolving surgical approach.
    • Evaluating the efficacy and safety of minimally invasive esophagectomy is crucial.

    Purpose:

    • To assess the oncological principles and short-term outcomes of minimally invasive esophagectomy in esophageal cancer patients.
    • To analyze complication rates and postoperative mortality associated with the procedure.

    Summary:

    • A study of 54 esophageal cancer patients (mean age 52.5 years, 66.6% male) undergoing minimally invasive esophagectomy between April 2012 and December 2014.
    • The majority (68.5%) received induction chemoradiation prior to surgery. Squamous cell carcinoma was prevalent (92.6%).
    • Complications occurred in 35.2% of patients, with a 3.7% postoperative mortality rate. The procedure adhered to oncological principles with tolerable short-term results.

    Impact:

    • Minimally invasive esophagectomy presents a safe and effective treatment option for esophageal cancer.
    • The findings support the adoption of minimally invasive techniques in esophageal cancer surgery.
    • This study contributes to the understanding of outcomes for minimally invasive esophagectomy in a real-world clinical setting.